Literature DB >> 14722019

Comparison of acute and chronic antioxidant interventions in experimental renovascular disease.

Alejandro R Chade1, James D Krier, Martin Rodriguez-Porcel, Jerome F Breen, Michael A McKusick, Amir Lerman, Lilach O Lerman.   

Abstract

Reactive oxygen species (ROS) can modulate renal hemodynamics and function both directly, by leading to vasoconstriction, and indirectly, by inducing renal inflammation and tissue growth. The involvement of oxidative stress in the pathogenesis of renovascular disease (RVD) is increasingly recognized, but the relative contribution of long-term tissue injury to renal dysfunction remains unclear. We hypothesized that functional and structural alterations elicited by oxidative stress in RVD would be more effectively modulated by chronic than by acute antioxidant intervention. Renal hemodynamics and function were quantified in vivo in pigs using electron-beam computed tomography at baseline and after vasoactive challenge (ACh and sodium nitroprusside); after 12 wk of RVD (simulated by concurrent hypercholesterolemia and renal artery stenosis, n = 7); RVD acutely infused with the SOD-mimetic tempol (RVD+tempol, n = 7); RVD chronically supplemented with antioxidant vitamins C (1 g) and E (100 IU/kg; RVD+vitamins, n = 7); or control (normal, n = 7). Renal tissue was studied ex vivo using immunoblotting and immunohistochemistry. Basal renal blood flow (RBF) and glomerular filtration rate were similarly decreased in all RVD groups. ACh-stimulated RBF remained unchanged in RVD, increased in RVD+tempol, but further increased (similarly to normal) in RVD+vitamins (P < 0.05 vs. RVD). Furthermore, RVD+vitamins also showed a decreased presence of superoxide anion, decreased NAD(P)H-oxidase and nitrotyrosine expression, increased endothelial nitric oxide synthase expression, and attenuated renal fibrosis. Chronic antioxidant intervention in early RVD improved renal hemodynamic responses more effectively than acute intervention, likely due to increased nitric oxide bioavailability and decreased structural injury. These suggest that chronic tissue changes play an important role in renal compromise mediated by oxidative stress in RVD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14722019     DOI: 10.1152/ajprenal.00385.2003

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  31 in total

Review 1.  Small Vessels, Big Role: Renal Microcirculation and Progression of Renal Injury.

Authors:  Alejandro R Chade
Journal:  Hypertension       Date:  2017-02-13       Impact factor: 10.190

Review 2.  Chronic renal ischemia in humans: can cell therapy repair the kidney in occlusive renovascular disease?

Authors:  Ahmed Saad; Sandra M Herrmann; Stephen C Textor
Journal:  Physiology (Bethesda)       Date:  2015-05

3.  Early superoxide scavenging accelerates renal microvascular rarefaction and damage in the stenotic kidney.

Authors:  Silvia Kelsen; Xiaochen He; Alejandro R Chade
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-23

4.  Phase 2a Clinical Trial of Mitochondrial Protection (Elamipretide) During Stent Revascularization in Patients With Atherosclerotic Renal Artery Stenosis.

Authors:  Ahmed Saad; Sandra M S Herrmann; Alfonso Eirin; Christopher M Ferguson; James F Glockner; Haraldur Bjarnason; Michael A McKusick; Sanjay Misra; Lilach O Lerman; Stephen C Textor
Journal:  Circ Cardiovasc Interv       Date:  2017-09       Impact factor: 6.546

5.  Effects of chronic quercetin treatment in experimental renovascular hypertension.

Authors:  María Francisca García-Saura; Milagros Galisteo; Inmaculada Concepción Villar; Almudena Bermejo; Antonio Zarzuelo; Félix Vargas; Juan Duarte
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

6.  Reversal of experimental renovascular hypertension restores coronary microvascular function and architecture.

Authors:  Victor H Urbieta-Caceres; Xiang-Yang Zhu; Matthew E Gibson; Frederic D Favreau; Kyra Jordan; Amir Lerman; Lilach O Lerman
Journal:  Am J Hypertens       Date:  2011-01-13       Impact factor: 2.689

7.  Adjunctive mesenchymal stem/stromal cells augment microvascular function in poststenotic kidneys treated with low-energy shockwave therapy.

Authors:  Xiao-Jun Chen; Xin Zhang; Kai Jiang; James D Krier; Xiangyang Zhu; Sabena Conley; Amir Lerman; Lilach O Lerman
Journal:  J Cell Physiol       Date:  2020-05-19       Impact factor: 6.384

8.  Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis.

Authors:  Martin Reriani; Eugenia Raichlin; Abhiram Prasad; Verghese Mathew; Geralyn M Pumper; Rebecca E Nelson; Ryan Lennon; Charanjit Rihal; Lilach O Lerman; Amir Lerman
Journal:  Circulation       Date:  2010-08-23       Impact factor: 29.690

Review 9.  Renovascular hypertension and ischemic nephropathy.

Authors:  Stephen C Textor; Lilach Lerman
Journal:  Am J Hypertens       Date:  2010-09-23       Impact factor: 2.689

10.  Role of renal microcirculation in experimental renovascular disease.

Authors:  Radu Iliescu; Solana R Fernandez; Silvia Kelsen; Christine Maric; Alejandro R Chade
Journal:  Nephrol Dial Transplant       Date:  2009-11-23       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.